Neurotoxin Use for Voiding Dysfunction

被引：0
作者：
Wang H.-J. [1 ]
Chuang Y.-C. [1 ]
Chancellor M.B. [2 ]
机构：
[1] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung
[2] Department of Urology, Oakland University William Beaumont School of Medicine, Royal Oak, MI, 48073, Suite 438
来源：
Current Bladder Dysfunction Reports | 2011年 / 6卷 / 3期
关键词：
Botulinum toxin; Detrusor-sphincter dyssynergia; Neurotoxin; Pelvic floor; Urethra; Voiding dysfunction;
D O I：
10.1007/s11884-011-0096-5
中图分类号：
学科分类号：
摘要：
Botulinum neurotoxin injection into the urethral sphincter has been shown to be effective in the treatment of neurogenic and non-neurogenic detrusor-sphincter dyssynergia. In this article, we review the rationale for, technique used in, and results of pelvic floor botulinum toxin injection. Clinicians should note that botulinum injection into the pelvic floor and urethral sphincter currently represents off-label use. © 2011 Springer Science+Business Media, LLC.
引用
收藏
页码：182 / 189
页数：7
相关论文
共 27 条
[1]  
Dykstra D.D., Sidi A.A., Scott A.B., Pagel J.M., Goldish G.D., Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients, J Urol., 139, 5, pp. 919-922, (1988)
[2]  
Smith C.P., Nishiguchi J., O'Leary M., Yoshimura N., Chancellor M.B., Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra, Urology., 65, 1, pp. 37-41, (2005)
[3]  
Smith C.P., O'Leary M., Erickson J., Somogyi G.T., Chancellor M.B., Botulinum toxin urethral sphincter injection resolves urinary retention after pubovaginal sling operation, Int Urogynecol J Pelvic Floor Dysfunct., 13, 1, pp. 55-56, (2002)
[4]  
Smith C.P., Chancellor M.B., Emerging role of botulinum toxin in the management of voiding dysfunction, J Urol., 171, 6 Pt 1, pp. 2128-2137, (2004)
[5]  
Novak I., Campbell L., Boyce M., Fung V.S., Botulinum toxin assessment, intervention and aftercare for cervical dystonia and other causes of hypertonia of the neck: international consensus statement, Eur J Neurol., 17, SUPPL. 2, pp. 94-108, (2010)
[6]  
Jabbari B., Botulinum neurotoxins in the treatment of refractory pain, Nat Clin Pract Neurol., 4, 12, pp. 676-685, (2008)
[7]  
Bhidayasiri R., Cardoso F., Truong D.D., Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations, Eur J Neurol., 13, SUPPL. 1, pp. 21-29, (2006)
[8]  
Albanese A., Terminology for preparations of botulinum neurotoxins: what a difference a name makes, JAMA., 305, 1, pp. 89-90, (2011)
[9]  
Chen S.L., Bih L.I., Chen G.D., Huang Y.H., You Y.H., Lew H.L., Transrectal ultrasound-guided transperineal botulinum toxin A injection to the external urethral sphincter for treatment of detrusor external sphincter dyssynergia in patients with spinal cord injury, Arch Phys Med Rehabil., 91, 3, pp. 340-344, (2010)
[10]  
de Seze M., Petit H., Gallien P., Et al., Botulinum A toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease, Eur Urol., 42, 1, pp. 56-62, (2002)
123